Real-World Evaluation of the Impact of the Anti-fibrotics in Patients with Idiopathic Pulmonary Fibrosis and Other Fibrotic Lung Diseases
B22. EMERGING MANAGEMENT OF FIBROTIC ILDs | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A2429-A2429
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2429